New Zealand markets close in 33 minutes
  • NZX 50

    11,618.01
    +65.97 (+0.57%)
     
  • NZD/USD

    0.6327
    +0.0029 (+0.47%)
     
  • NZD/EUR

    0.6064
    +0.0021 (+0.35%)
     
  • ALL ORDS

    7,541.40
    +60.70 (+0.81%)
     
  • ASX 200

    7,342.60
    +58.40 (+0.80%)
     
  • OIL

    80.35
    -0.20 (-0.25%)
     
  • GOLD

    1,788.30
    +28.40 (+1.61%)
     
  • NASDAQ

    12,030.06
    +526.61 (+4.58%)
     
  • FTSE

    7,573.05
    +61.05 (+0.81%)
     
  • Dow Jones

    34,589.77
    +737.24 (+2.18%)
     
  • DAX

    14,397.04
    +41.59 (+0.29%)
     
  • Hang Seng

    18,832.20
    +234.97 (+1.26%)
     
  • NIKKEI 225

    28,281.04
    +312.05 (+1.12%)
     
  • NZD/JPY

    86.5040
    -0.3830 (-0.44%)
     

The Global Bioinformatics Market to Surpass USD 46 Billion by 2027 | DelveInsight

DelveInsight Business Research LLP
DelveInsight Business Research LLP

The bioinformatics market is experiencing positive growth as a result of rising demand for both nucleic acid and protein sequencing, increased demand for integrated data, and technological innovation in product development, all of which are contributing to the bioinformatics market growth during the forecast period of 2022–2027.

New York, USA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The Global Bioinformatics Market to Surpass USD 46 Billion by 2027 | DelveInsight

The bioinformatics market is experiencing positive growth as a result of rising demand for both nucleic acid and protein sequencing, increased demand for integrated data, and technological innovation in product development, all of which are contributing to the bioinformatics market growth during the forecast period of 2022–2027.

DelveInsight’s Bioinformatics Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, bioinformatics market drivers, barriers, and trends, and key bioinformatics companies in the market. 

Key Takeaways from the Bioinformatics Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global bioinformatics market during the forecast period.

  • Notable bioinformatics companies such as Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, Waters Corporation, DNASTAR, Fios Genomics, Partek Incorporated, SOPHiA Genetics, Source Bioscience, Biomax Informatics AG, Seven Bridges Genomics Inc., and several others are currently operating in the bioinformatics market.

  • On March 02, 2022, BISC Global, a Bioinformatics, Biostatistics, and ML/AI consulting company, is partnering with cropSeq bioinformatics, a company specialized in AgriGenomics consulting, to address the most pressing challenges in data-driven agriculture and plant research.

  • In February 2022, Bruker Corporation announced its TIMS DIA-NN software for the high-throughput, deep and unbiased 4D proteomics workflow.

To read more about the latest highlights related to the bioinformatics pipeline, get a snapshot of the key highlights entailed in the Global Bioinformatics Market Report 

Bioinformatics Overview

Bioinformatics is the application of computer technology to the management and analysis of biological data. It involves the storage, analysis, and dissemination of biological data. Bioinformatics employs computer programs to perform various tasks, such as determining gene and protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins.

There are several bioinformatics tools on the market. They are classified as protein functional and analysis tools, homology and similarity tools, sequence analysis tools, and miscellaneous tools. The field encompasses many advanced and specialized areas of life, including structural genomics, functional genomics, DNA microarrays, comparative genomics, and medical information.


Bioinformatics Market Insights

North America is expected to account for the largest share of the global bioinformatics market. The rising prevalence of the COVID-19 pandemic, the increased demand for personalized medicine in this region, and the release of new and innovative bioinformatics software will all contribute to the growth of the bioinformatics market.

For example, on March 7, 2022, Arup announced the launch of Rio, a new world-class bioinformatics pipeline and analytics platform. It expands the ARUP's existing cloud computing capabilities to move data more efficiently and accurately, allowing clinicians to receive targeted test results faster and make better patient medical decisions.

As a result, all of the factors mentioned above are expected to propel the bioinformatics market in the United States region.

To know more about why North America is leading the market growth in the bioinformatics market, get a snapshot of the Bioinformatics Market Trends

Bioinformatics Market Dynamics

The bioinformatics market is experiencing increased product demand for a variety of reasons. The increasing demand for nucleic acid and protein sequencing is the primary driver of the bioinformatics market. Furthermore, the bioinformatics platform enables scientists and clinicians to explore and analyze both omics and clinical data in a single environment based on a robust, scalable cloud platform, resulting in precision drug discovery programs. These platforms will help the industry grow even more.

Furthermore, the need for disease management, prevention, and treatment and advancements in bioinformatics drive bioinformatics market growth. Additionally, the COVID-19 pandemic and the demand for newer treatments and vaccines will drive up the demand for nucleic acid and protein sequencing. As a result of the rising demand for nucleic acid and protein sequencing, there will be an increase in demand for bioinformatics, fueling the growth of the bioinformatics market.

However, higher costs associated with bioinformatics software and services, as well as a scarcity of skilled professionals, may be limiting factors in the growth of the bioinformatics market.

Moreover, the unprecedented COVID-19 outbreak significantly impacted the bioinformatics market. Most importantly, the current COVID-19 pandemic and rising demand for newer treatments and vaccines contribute to improved opportunities in the global bioinformatics market. Regarding providing critical support to various areas of scientific research, bioinformatics has always had enormous potential.

Get a sneak peek at the bioinformatics market dynamics @Bioinformatics Market Dynamics Analysis

Report Metrics

Details

Coverage

Global

Study Period

2019–2027

Base Year

2021

Market CAGR

15.14%

Market Size in 2021

USD 20.12 Billion

Anticipated Market Size by 2027

USD 46.88 Billion

Key Bioinformatics Companies

Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, Waters Corporation, DNASTAR, Fios Genomics, Partek Incorporated, SOPHiA Genetics, Source Bioscience, Biomax Informatics AG, Seven Bridges Genomics Inc., among others

Bioinformatics Market Segmentation 

  • Market Segmentation By Type: Bioinformatics Products, Bioinformatics Services

  • Market Segmentation By Bioinformatics Product: Knowledge Management Tools, Bioinformatics Platforms

  • Market Segmentation By Application: Genomics, Proteomics, Transcriptomics, Others

  • Market Segmentation By Sector: Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Others

  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World

  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the bioinformatics services market are set to emerge as the trendsetter explore @Bioinformatics Companies 

Table of Contents 

1

Report Introduction

2

Executive summary

3

Regulatory and Patent Analysis

4

Key Factors Analysis

5

Porter’s Five Forces Analysis

6

COVID-19 Impact Analysis on Bioinformatics Market

7

Bioinformatics Market Layout

8

Global Company Share Analysis – Key 3-5 Companies

9

Bioinformatics Market Company and Product Profiles

10

Project Approach

11

About DelveInsight

Interested in knowing the bioinformatics market by 2027? Click to get a snapshot of the Bioinformatics Market Research

Related Reports

DNA Sequencing Market

DNA Sequencing Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key DNA sequencing companies, including Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, among others.

Biosimilars Market

Biosimilars Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biosimilars companies, including Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Amgen, Inc., Eli Lilly and Company, Novartis AG, Bioeq AG, among others.

Drug Delivery Devices Market

Drug Delivery Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key drug delivery devices companies, including Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis, among others.

Novel Drug Delivery Devices Market

Novel Drug Delivery Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key novel drug delivery devices companies, including Pfizer, Johnson & Johnson Services, Roche, Novartis, among others.

Drug Infusion Systems Market

Drug Infusion Systems Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key drug infusion systems companies, including B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, among others.

Transdermal Drug Delivery Devices Market

Transdermal Drug Delivery Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key transdermal drug delivery devices companies, including Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, among others.

Other Trending Reports

Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Weight Loss/Weight Management (Obesity) Market | Food Allergy Market | Obsessive-Compulsive Disorder Market | Tumor Ablation Market | Bioinformatics Market | CAR-T Pipeline Insight | Anti-hypertension Market | Radiofrequency Ablation Devices Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market | Gastro Intestinal Bleeding Market | Trastuzumab Biosimilars Insight | Varicose Veins Market | Germ Cell Tumor Market | Intracardiac Echocardiography Devices Market | India Healthcare Outlook Report | Crows Feet Market Insight | Seborrhoeic Dermatitis Market | Injectable Drug Delivery Devices Market | Structural Heart Devices Market | Substance (Drug) Abuse Market

Related Blogs

Artificial Intelligence in Drug Discovery

Commerical Launch of Biopharmaceutical Products

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

CONTACT: Contact Us Shruti Thakur  info@delveinsight.com  +1(919)321-6187  https://www.delveinsight.com/medical-devices